Literature DB >> 7930642

Isolation of IgG antibody Fv-DNA from various mouse and rat hybridoma cell lines using the polymerase chain reaction with a simple set of primers.

S Dübel1, F Breitling, P Fuchs, M Zewe, S Gotter, M Welschof, G Moldenhauer, M Little.   

Abstract

To facilitate the isolation of IgG antibody Fv-DNA sequences from hybridoma cell lines, we have established a polymerase chain reaction (PCR) procedure requiring only a small number of primers. The sense primers homologous to DNA coding for the first framework sequences were designed to hybridize to all the known antibody sequences under conditions that permit a high number of mismatches. The antisense primers were homologous to DNA coding for the beginning of the constant regions of the gamma and kappa chains. Restriction sites introduced by the primers enable the DNA to be cloned into bacterial expression vectors. Only three sense VH primers and two sense VL primers paired with one backward primer for the heavy and light chains, respectively, were necessary for the amplification of Fv-DNA from a total of 17 rodent cell lines that we have so far worked with. These consisted of 12 mouse cell lines and five rat cell lines. This procedure will therefore probably be sufficient to isolate the Fv-DNA from most mouse cell lines and possibly also from most rat cell lines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930642     DOI: 10.1016/0022-1759(94)90334-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

1.  Molecular and idiotypic analyses of the antibody response to Cryptococcus neoformans glucuronoxylomannan-protein conjugate vaccine in autoimmune and nonautoimmune mice.

Authors:  G Nussbaum; S Anandasabapathy; J Mukherjee; M Fan; A Casadevall; M D Scharff
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formation.

Authors:  Rudy E Fuentes; Sergei Zaitsev; Hyun Sook Ahn; Vincent Hayes; M Anna Kowalska; Michele P Lambert; Yuhuan Wang; Donald L Siegel; Daniel W Bougie; Richard H Aster; Daniel D Myers; Victoria Stepanova; Douglas B Cines; Vladimir R Muzykantov; Mortimer Poncz
Journal:  J Clin Invest       Date:  2016-02       Impact factor: 14.808

3.  Molecular engineering of high affinity single-chain antibody fragment for endothelial targeting of proteins and nanocarriers in rodents and humans.

Authors:  Colin F Greineder; Elizabeth D Hood; Anning Yao; Makan Khoshnejad; Jake S Brenner; Ian H Johnston; Mortimer Poncz; Claudia Gottstein; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2016-02-06       Impact factor: 9.776

4.  Dual targeting of therapeutics to endothelial cells: collaborative enhancement of delivery and effect.

Authors:  Colin F Greineder; Jacob B Brenza; Ronald Carnemolla; Sergei Zaitsev; Elizabeth D Hood; Daniel C Pan; Bi-Sen Ding; Charles T Esmon; Ann Marie Chacko; Vladimir R Muzykantov
Journal:  FASEB J       Date:  2015-05-07       Impact factor: 5.191

5.  A simple methodology for conversion of mouse monoclonal antibody to human-mouse chimeric form.

Authors:  Vinh T Dang; Kedar D Mandakhalikar; Oi-Wing Ng; Yee-Joo Tan
Journal:  Clin Dev Immunol       Date:  2013-09-02

6.  Identification of Immunoglobulin Gene Sequences from a Small Read Number of mRNA-Seq Using Hybridomas.

Authors:  Yuki Kuniyoshi; Kazumitsu Maehara; Takeshi Iwasaki; Masayasu Hayashi; Yuichiro Semba; Masatoshi Fujita; Yuko Sato; Hiroshi Kimura; Akihito Harada; Yasuyuki Ohkawa
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

7.  ER intrabody-mediated inhibition of interferon α secretion by mouse macrophages and dendritic cells.

Authors:  Konrad Büssow; Philipp Themann; Sabine Luu; Paul Pentrowski; Claudia Harting; Mira Majewski; Veith Vollmer; Mario Köster; Martina Grashoff; Rainer Zawatzky; Joop Van den Heuvel; Andrea Kröger; Thomas Böldicke
Journal:  PLoS One       Date:  2019-04-16       Impact factor: 3.240

8.  Development of a humanized antibody with high therapeutic potential against dengue virus type 2.

Authors:  Pi-Chun Li; Mei-Ying Liao; Ping-Chang Cheng; Jian-Jong Liang; I-Ju Liu; Chien-Yu Chiu; Yi-Ling Lin; Gwong-Jen J Chang; Han-Chung Wu
Journal:  PLoS Negl Trop Dis       Date:  2012-05-01

9.  Vascular immunotargeting to endothelial determinant ICAM-1 enables optimal partnering of recombinant scFv-thrombomodulin fusion with endogenous cofactor.

Authors:  Colin F Greineder; Ann-Marie Chacko; Sergei Zaytsev; Blaine J Zern; Ronald Carnemolla; Elizabeth D Hood; Jingyan Han; Bi-Sen Ding; Charles T Esmon; Vladimir R Muzykantov
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

Review 10.  Specific in vivo knockdown of protein function by intrabodies.

Authors:  Andrea L J Marschall; Stefan Dübel; Thomas Böldicke
Journal:  MAbs       Date:  2015-08-07       Impact factor: 5.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.